---
id: k-dense-beta-biostate
slug: k-dense-beta-biostate
entity_type: commercial
status: operational
data_completeness: very_high
last_researched: 2025-01-27
researcher: AI Assistant
version: 2.1
name: K-Dense Beta by Biostate AI
description: Multi-agent AI research system that compresses research cycles from years to days. Validated with Harvard Medical School longevity research breakthrough, achieving 95% accuracy in transcriptomic clock building and surpassing frontier AI models on BixBench benchmark.
mission: To develop generative AI agentic systems that accelerate biomedical discovery and transform how we understand, predict, and ultimately control human health. The company aims to compress research cycles from years to days while eliminating hallucinations that plague generative AI models, enabling faster validation of therapies and interventions.
entity_data:
  focus: Developing generative AI agentic systems to accelerate biomedical discovery and transform how we understand, predict, and ultimately control human health. Platform includes K-Dense (multi-agent AI system for scientific discovery), N-ACT (foundation model for interpreting biological data), and patented sequencing technologies.
  founded: 2023
  website: "https://www.biostate.ai/"
  industry: Biotechnology / AI
  employees:
  note: Information not publicly disclosed
  as_of: 2025
  legal_name: Biostate AI, Inc.
  headquarters:
  city: Houston
  state: Texas
  address: 7505 Fannin St. Suite 610, Houston, TX 77054
  country: USA
taxonomy:
  geography: USA
  ai_approach:
  - Generative AI
  ai_technology:
  - Generative AI
  - LLMs
  - Multi-Agent AI
  primary_focus:
  - Autonomous AI Scientists
  aging_approach:
  - Target Discovery
  target_biology:
  - General Aging/Longevity
  ai_architecture:
  - LLMs
  ai_specialization:
  - Multi-Agent AI
  development_stage: operational
  organization_type: commercial
  organization_subtype: operational
  therapeutic_modality: []
organizations:
  -
    name: Weill Cornell Medicine
    role: partner
    org_type: institution
  -
    name: Mass General Brigham
    role: partner
    org_type: institution
  -
    name: David Sinclair Lab - Harvard Medical School
    role: partner
    org_type: institution
    website: "https://sinclair.hms.harvard.edu/"
    status: operational
  -
    name: Accelerated Cure Project
    role: partner
    org_type: nonprofit
  -
    name: Narayana Health
    role: partner
    org_type: institution
  -
    name: Kindstar Global Gene Technology
    role: partner
    org_type: company
  -
    name: Zafrens
    role: partner
    org_type: company
  -
    name: Biostate AI
    role: primary
    org_type: company
    legal_name: Biostate AI, Inc.
    founded: 2023
    website: "https://www.biostate.ai/"
    status: operational
products:
  -
    name: N-ACT
    type: ai_model
    status: In development
    development_stage: development
  -
    name: MARE
    type: research_methodology
    status: Operational
    development_stage: operational
  -
    name: K-Dense Beta
    type: platform
    status: Beta - Available to select design partners
    development_stage: beta
  -
    name: PERD
    type: research_methodology
    status: Operational
    development_stage: operational
  -
    name: BIRT (Barcode-Integrated Reverse Transcription)
    type: research_methodology
    status: Operational
    development_stage: operational
links:
  -
    url: "https://longevity.technology/news/new-ai-tool-demonstrates-potential-to-accelerate-longevity-research/"
    type: news_article
    title: New AI Tool Demonstrates Potential to Accelerate Longevity Research
  -
    url: "https://www.globenewswire.com/news-release/2025/07/24/3121102/0/en/Biostate-AI-unlocks-molecular-doors-to-global-health-with-alliances-from-Boston-to-Bengaluru.html"
    type: press_release
    title: Biostate AI Unlocks Molecular Doors to Global Health with Alliances from Boston to Bengaluru
  -
    url: "https://arxiv.org/abs/2508.07043"
    type: research_publication
    title: "K-Dense Analyst: Towards Fully Automated Scientific Analysis"
  -
    url: "https://www.businesswire.com/news/home/20240708652997/en/Biostate-AI-Launches-Total-RNA-Sequencing-and-Free-Data-Analysis-AI"
    type: press_release
    title: Biostate AI Launches Total RNA Sequencing and Free Data Analysis AI
  -
    url: "https://www.globenewswire.com/news-release/2025/09/17/3151632/0/en/Biostate-AI-Launches-K-Dense-Beta-an-AI-Agent-That-Compresses-Research-Cycles-from-Years-to-Days-Validated-with-Harvard-Longevity-Discovery-Breakthrough.html"
    type: press_release
    title: Biostate AI Launches K-Dense Beta, an AI Agent That Compresses Research Cycles from Years to Days; Validated with Harvard Longevity Discovery Breakthrough
  -
    url: "https://www.startuphub.ai/ai-news/sponsored-press-release/2025/biostate-ai-expands-global-reach-with-strategic-partnerships-in-us-china-and-india/"
    type: press_release
    title: Biostate AI Expands Global Reach with Strategic Partnerships in US, China, and India
  -
    url: "https://www.entrepreneur.com/en-in/news-and-trends/biostate-ai-raises-usd-12-mn-series-a-led-by-accel/491974"
    type: news_article
    title: Biostate AI Raises USD 12 Mn Series A Led by Accel
  -
    url: "https://sahyadristartups.com/spotlight/k-dense-beta-outperforms-gpt-5-in-bioinformatics-benchmark-tests/"
    type: news_article
    title: K-Dense Beta Outperforms GPT-5 in Bioinformatics Benchmark Tests
  -
    url: "https://hlth.com/insights/news/biostate-ai-raises-12m-series-a-to-transform-rna-sequencing-for-precision-medicine-2025-05-21"
    type: news_article
    title: Biostate AI Raises $12M Series A to Transform RNA Sequencing for Precision Medicine
  -
    url: "https://www.businesswire.com/news/home/20250422686955/en/Biostate-AI-and-Weill-Cornell-Medicine-Collaborate-to-Develop-AI-Models-for-Personalized-Leukemia-Care"
    type: press_release
    title: Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia Care
  -
    url: "https://discover-pharma.com/biostate-ai-launches-k-dense-beta-to-accelerate-biological-discovery-from-years-to-days/"
    type: news_article
    title: Biostate AI Launches K-Dense Beta to Accelerate Biological Discovery from Years to Days
  -
    url: "https://www.prnewswire.com/news-releases/biostate-ais-indian-subsidiary-bayosthiti-partners-with-narayana-health-to-build-worlds-largest-india-specific-cardiac-ai-dataset-302598587.html"
    type: press_release
    title: "Biostate AI's Indian Subsidiary Bayosthiti Partners with Narayana Health to Build World's Largest India-Specific Cardiac AI Dataset"
  -
    url: "https://www.prnewswire.com/news-releases/biostate-ai-and-accelerated-cure-project-partner-to-develop-ai-models-for-multiple-sclerosis-302431207.html"
    type: press_release
    title: Biostate AI and Accelerated Cure Project Partner to Develop AI Models for Multiple Sclerosis
---

# K-Dense Beta by Biostate AI

## Description

Multi-agent AI research system that compresses research cycles from years to days. Validated with Harvard Medical School longevity research breakthrough, achieving 95% accuracy in transcriptomic clock building and surpassing frontier AI models on BixBench benchmark.

## Mission

To develop generative AI agentic systems that accelerate biomedical discovery and transform how we understand, predict, and ultimately control human health. The company aims to compress research cycles from years to days while eliminating hallucinations that plague generative AI models, enabling faster validation of therapies and interventions.

## Company Information

**Legal Name**: Biostate AI, Inc.
**Founded**: 2023
**Industry**: Biotechnology / AI
**Employees**: {"note":"Information not publicly disclosed","as_of":"2025"}
**Focus**: Developing generative AI agentic systems to accelerate biomedical discovery and transform how we understand, predict, and ultimately control human health. Platform includes K-Dense (multi-agent AI system for scientific discovery), N-ACT (foundation model for interpreting biological data), and patented sequencing technologies.
**Website**: https://www.biostate.ai/

## Scientific Background

```yaml
multi_agent_system: "The system coordinates specialized agents for experiment planning, literature review, analysis design, code execution in secure sandboxes, and publication-ready report generation. It integrates with bioinformatics pipelines, tools like Google's AlphaFold, curated databases, and specialized LLMs like MedGemma. Agents work as a team of independent scientific reviewers, cross-checking each other's work."
bixbench_performance: K-Dense achieved 29.2% accuracy on BixBench benchmark, one of the most rigorous bioinformatics benchmarks for open-ended biological analysis. This surpassed frontier models including GPT-5 (22.9%), GPT-4o (18%), and Claude 3.5 Sonnet (18%), representing a 6.3 percentage point improvement over GPT-5 (nearly 27% relative improvement), demonstrating superior performance in scientific analysis tasks.
k_dense_architecture: K-Dense Beta is a hierarchical multi-agent AI system that coordinates specialized agents to perform complete research cycles. It uses a dual-loop architecture with Reflexion for validation, cross-checking references against external databases, and feedback loops to eliminate hallucinations common in generative AI models.
transcriptomic_clocks:
  description: "Transcriptomic clocks predict biological age from RNA expression profiles. Traditional clocks assume a uniform aging process, but K-Dense's analysis revealed that aging is non-uniform."
  biological_insight: The finding that aging is a sequence of biological programs challenges the traditional view of aging as a uniform process and suggests that interventions may need to be stage-specific.
  k_dense_contribution: K-Dense analyzed over 600,000 transcriptomic profiles to build aging clocks, identifying 5,000 genes and achieving 95% accuracy. The system discovered that different sets of RNA transcripts become important predictors at different life stages, indicating aging is a sequence of biological programs requiring individual predictive models for each stage rather than a single universal clock.
model_context_protocol: K-Dense uses Model Context Protocol (MCP), a universal protocol that allows AI systems to access and coordinate external software, enabling modular connection to any available tool. This provides flexibility and extensibility, allowing the system to adapt to new tools and databases as they become available.
biological_justification:
  non_uniform_aging: The discovery that different RNA transcripts are important at different life stages aligns with biological understanding that aging involves multiple processes (cellular senescence, DNA damage, epigenetic changes) that occur at different rates and times.
  stage_specific_models: The need for stage-specific models reflects the complexity of aging, where different biological programs are active at different life stages (development, maturity, senescence).
  therapeutic_implications: This finding suggests that anti-aging interventions may need to be stage-specific, targeting different pathways at different life stages.
comparison_with_existing_methods:
  manual_research: Traditional research cycles take months to years. K-Dense compresses this to days or weeks while maintaining high accuracy.
  other_ai_systems: Unlike single-model AI systems, K-Dense uses multi-agent coordination with verification, eliminating hallucinations that plague generative AI models.
  traditional_clocks: Traditional aging clocks (e.g., Horvath clock) assume uniform aging process. K-Dense revealed that aging is non-uniform, requiring stage-specific models.
```

## Performance Metrics

```yaml
improvement: 6.3 percentage points over GPT-5, representing nearly 27% relative improvement
time_compression: Compresses research cycles from years to days (weeks vs months/years)
bixbench_accuracy: "29.2% (vs GPT-5: 22.9%, GPT-4o: 18%, Claude 3.5 Sonnet: 18%)"
transcriptomic_clock_accuracy: 95% accuracy in predicting biological age
```

## Lessons Learned

### Achievements

- Successfully compressed research cycles from years to days
- Achieved 95% accuracy in transcriptomic clock building with 5,000 genes identified
- Surpassed frontier AI models (GPT-5, GPT-4o, Claude 3.5 Sonnet) on BixBench benchmark
- Discovered 4 new RNA proteins related to aging in collaboration with Harvard's Sinclair Lab
- Validated system with leading medical institutions
- Demonstrated that aging is a non-uniform process requiring stage-specific predictive models

### Challenges

- Eliminating hallucinations in generative AI models for scientific research
- Coordinating multiple specialized AI agents for complex research tasks
- Validating AI-generated scientific findings with high accuracy
- Scaling analysis to hundreds of thousands of transcriptomic profiles

### Impact on Field

K-Dense Beta represents a significant advancement in AI-driven scientific research automation. By compressing research cycles from years to days while maintaining high accuracy, it enables faster validation of reprogramming therapies and aging interventions. The system's ability to analyze massive datasets (600k+ profiles) and identify novel biological insights demonstrates the transformative potential of multi-agent AI systems in longevity research and biomedical discovery.

## Organizations

### Weill Cornell Medicine
**Role in Project**: partner
**Organization Type**: institution
**Description**: Academic medical center
**Focus**: Personalized leukemia care, disease prognosis AI

### Mass General Brigham
**Role in Project**: partner
**Organization Type**: institution
**Description**: Integrated academic healthcare system
**Focus**: Melanoma immunotherapy AI models

### David Sinclair Lab - Harvard Medical School
**Role in Project**: partner
**Organization Type**: institution
**Status**: operational
**Website**: https://sinclair.hms.harvard.edu/
**Description**: David Sinclair's laboratory at Harvard Medical School, focusing on longevity research and aging interventions. The lab collaborates with Biostate AI on experimental design optimization for organoid testing.
**Focus**: Longevity research, transcriptomic aging clocks, biological age prediction

### Accelerated Cure Project
**Role in Project**: partner
**Organization Type**: nonprofit
**Description**: Nonprofit organization focused on multiple sclerosis research
**Focus**: Multiple sclerosis AI models, disease progression prediction

### Narayana Health
**Role in Project**: partner
**Organization Type**: institution
**Description**: Healthcare provider in India
**Focus**: Cardiovascular disease prediction for Indian populations

### Kindstar Global Gene Technology
**Role in Project**: partner
**Organization Type**: company
**Description**: Global gene technology company
**Focus**: China market adaptation, RNA sequencing platform

### Zafrens
**Role in Project**: partner
**Organization Type**: company
**Description**: Drug discovery company
**Focus**: Drug discovery acceleration

### Biostate AI
**Legal Name**: Biostate AI, Inc.
**Role in Project**: primary
**Organization Type**: company
**Status**: operational
**Founded**: 2023
**Website**: https://www.biostate.ai/
**Description**: Developing generative AI agentic systems to accelerate biomedical discovery and transform how we understand, predict, and ultimately control human health
**Focus**: Developing generative AI agentic systems to accelerate biomedical discovery and transform how we understand, predict, and ultimately control human health. Platform includes K-Dense (multi-agent AI system for scientific discovery), N-ACT (foundation model for interpreting biological data), and patented sequencing technologies.

## Locations

### Biostate AI Houston Headquarters
**Type**: headquarters
**Address**: 7505 Fannin St. Suite 610, Houston, TX 77054
**City**: Houston
**State/Region**: Texas
**Country**: USA
**Organizations**: Biostate AI

## Products

### N-ACT
**Alternative Names**: N-ACT Foundation Model
**Type**: ai_model
**Status**: In development
**Development Stage**: development
**Role in Project**: secondary
**Relationship Description**: Foundation model for interpreting biological data
**Description**: Foundation model for interpreting biological data, designed to understand and predict biological processes from multi-omic data
**Mechanism of Action**: Foundation model for interpreting biological data, designed to understand and predict biological processes from multi-omic data
**Target**: Biological data interpretation
**Pathway**: Multi-omic data analysis and interpretation
**Indications**: [
  {
    "primary": "Biological data interpretation",
    "secondary": [
      "RNA sequencing analysis",
      "Multi-omic integration",
      "Biological process prediction"
    ]
  }
]

### MARE
**Type**: research_methodology
**Status**: Operational
**Development Stage**: operational
**Role in Project**: component
**Relationship Description**: Patented technology for newborn screening using RNA sequencing
**Description**: Patented technology that enables newborn screening using RNA sequencing
**Mechanism of Action**: Patented technology that enables newborn screening using RNA sequencing
**Target**: Newborn screening
**Indications**: [
  {
    "primary": "Newborn screening",
    "secondary": [
      "Early disease detection",
      "Preventive diagnostics"
    ]
  }
]

### K-Dense Beta
**Alternative Names**: K-Dense
**Type**: platform
**Status**: Beta - Available to select design partners
**Development Stage**: beta
**Role in Project**: primary
**Relationship Description**: Primary product: Multi-agent AI research system for scientific discovery
**Description**: Comprehensive multi-agent AI research system that coordinates specialized agents to plan experiments, review literature, design analyses, execute code in secure sandboxes, and generate publication-ready reports
**Mechanism of Action**: Comprehensive multi-agent AI research system that coordinates specialized agents to plan experiments, review literature, design analyses, execute code in secure sandboxes, and generate publication-ready reports. Uses dual-loop architecture with Reflexion for validation and cross-checking references against external databases to eliminate hallucinations.
**Target**: Scientific research automation
**Pathway**: Full research cycle automation from hypothesis to publication
**Capabilities**:
- Experiment planning
- Literature review
- Analysis design
- Code execution in secure sandboxes
- Publication-ready report generation
**Applications**:
- Biomedical research acceleration
- Longevity research
- Transcriptomic clock building
- Drug discovery
- Experimental design optimization
**Indications**: [
  {
    "primary": "Biomedical research acceleration",
    "secondary": [
      "Longevity research",
      "Transcriptomic clock building",
      "Drug discovery",
      "Experimental design optimization"
    ]
  }
]
**Technical Details**:
```yaml
notes: "Beta version launched September 17, 2025. Broader availability planned for later in 2025. Built on Google Cloud's Gemini 2.5 Pro. Integrates with bioinformatics pipelines, tools like Google's AlphaFold, curated databases, and specialized LLMs like MedGemma. Uses Model Context Protocol (MCP) for modular connection to external tools."
architecture:
  type: Hierarchical multi-agent AI system
  base_model: "Google Cloud's Gemini 2.5 Pro"
  key_feature: Autonomous bioinformatics analysis through hierarchical agent coordination
  design_principle: Dual-loop architecture combining planning with verified execution
research_studies:
  -
    name: Harvard Medical School Longevity Research Study
    phase: Validation Study
    design: Analysis of over 600,000 transcriptomic profiles to build transcriptomic-based aging clocks. K-Dense selected 60,000 high-quality samples from the initial 600,000+ profiles and focused on 5,000 genes out of more than 50,000 available genes.
    status: Completed
    results:
    summary: K-Dense achieved industry-leading accuracy while accelerating biological discovery from years to days. The system demonstrated that different sets of RNA transcripts become important predictors at different life stages, showing that aging is a non-uniform process requiring separate predictive models for each stage.
    accuracy: 95%
    discovery: "Identified 4 new RNA proteins related to aging in collaboration with David Sinclair's lab at Harvard Medical School"
    validation: Results validated with Harvard Medical School and submitted for peer review. Preprint available on bioRxiv, awaiting peer-reviewed journal publication.
    key_finding: Different sets of RNA transcripts become important predictors at different life stages, indicating aging is a sequence of biological programs requiring individual predictive models
    genes_available: 50,000+
    genes_identified: 5,000 genes
    samples_analyzed: 600,000+ transcriptomic profiles
    samples_selected: 60,000 high-quality samples
    time_compression: Compressed research cycles from years to days. Professor Sinclair noted the research was completed in weeks instead of months or years.
    benchmark_performance:
    accuracy: 29.2%
    benchmark: BixBench
    comparison:
    GPT-5: 22.9%
    GPT-4o: 18%
    Claude_3.5_Sonnet: 18%
    description: One of the most rigorous bioinformatics benchmarks for open-ended biological analysis
    improvement_over_gpt5: 6.3 percentage points (27% relative improvement)
    indication: Transcriptomic aging clock development
    start_date: 2025
  -
    name: Zafrens Drug Discovery Acceleration
    phase: Validation Study
    status: Completed
    results:
    summary: K-Dense accelerated a three-month research project to four days, discovering previously unrecognized patterns of cell states associated with compound response
    collaborator: Swamy Vijayan, CEO Zafrens
    time_compression: 3 months to 4 days
    indication: Drug discovery pattern recognition
    start_date: 2025
secure_sandboxes:
  purpose: Ensures safety, prevents errors from affecting other parts of the system, and enables verification of results
  description: Code execution occurs in secure, isolated computational environments
  verification: Each code execution is verified before results are used in subsequent steps
specialized_agents:
  coordination: All agents work together as a team of independent scientific reviewers, cross-checking references against external databases and adding feedback loops for increased accuracy
  code_executor: Agent that executes code in secure sandboxes with verification
  report_generator: Agent that generates publication-ready reports with proper citations and formatting
  analysis_designer: Agent that designs statistical analyses and bioinformatics pipelines
  experiment_planner: Agent responsible for designing experimental protocols and research plans
  literature_reviewer: Agent that reviews scientific literature, extracts relevant information, and synthesizes knowledge
performance_metrics:
  improvement: 6.3 percentage points over GPT-5, representing nearly 27% relative improvement
  time_compression: Compresses research cycles from years to days (weeks vs months/years)
  bixbench_accuracy: "29.2% (vs GPT-5: 22.9%, GPT-4o: 18%, Claude 3.5 Sonnet: 18%)"
  transcriptomic_clock_accuracy: 95% accuracy in predicting biological age
dual_loop_architecture:
  description: K-Dense uses a dual-loop architecture that combines planning with verified execution. The system employs specialized agents that break down complex tasks into executable, verifiable subtasks within secure computational environments.
  planning_loop: High-level planning agents decompose complex research tasks into manageable subtasks, coordinate specialized agents, and manage the overall research workflow
  execution_loop: Specialized execution agents perform specific tasks (experiment planning, literature review, analysis design, code execution) in secure sandboxes with verification at each step
  reflexion_mechanism: Reflexion validation ensures each step is cross-checked through cycles of self-review and correction, refining hypotheses and enabling early error detection for more reliable scientific reasoning
hallucination_prevention:
  mechanism: K-Dense eliminates hallucinations by working as a team of independent scientific reviewers
  feedback_loops: Multiple feedback loops ensure accuracy at each step of the research process
  cross_referencing: Agents cross-check references against external databases to verify claims
  verified_execution: Code execution in secure sandboxes with verification prevents errors from propagating
integration_capabilities:
  external_tools:
  medgemma: Specialized large language models like MedGemma for biomedical text understanding
  alphafold: "Integration with Google's AlphaFold for protein structure prediction"
  curated_databases: Access to curated biological databases for reference checking
  model_context_protocol:
  benefit: Enables modular connection to any available tool, providing flexibility and extensibility
  description: K-Dense uses Model Context Protocol (MCP), a universal protocol that allows AI systems to access and coordinate external software
  bioinformatics_pipelines: Access to standard bioinformatics pipelines and tools
```

### PERD
**Type**: research_methodology
**Status**: Operational
**Development Stage**: operational
**Role in Project**: component
**Relationship Description**: Patented sequencing technology for multi-omic data collection
**Description**: Patented technology used in Biostate's wetlab platform for efficient collection of transcriptomic and genomic data with unprecedented scale and cost-effectiveness
**Mechanism of Action**: Patented technology used in Biostate's wetlab platform for efficient collection of transcriptomic and genomic data with unprecedented scale and cost-effectiveness
**Target**: Multi-omic data collection

### BIRT (Barcode-Integrated Reverse Transcription)
**Type**: research_methodology
**Status**: Operational
**Development Stage**: operational
**Role in Project**: component
**Relationship Description**: Patented sequencing technology for RNA and DNA sequencing
**Description**: Patented technology enabling large-scale, high-fidelity RNA and DNA sequencing for real biological data generation
**Mechanism of Action**: Patented technology enabling large-scale, high-fidelity RNA and DNA sequencing for real biological data generation. Reduces cost of multi-omic data collection by up to 10x.
**Target**: RNA sequencing
**Indications**: [
  {
    "primary": "Total RNA sequencing",
    "secondary": [
      "Cost-effective multi-omic data collection",
      "Large-scale sequencing projects"
    ]
  }
]

## Key People

### David Sinclair
**Title**: Professor
**Participation Type**: researcher
**Role in Project**: Professor, Co-director of the Paul F. Glenn Center for Biology of Aging Research
**Affiliations**: Harvard Medical School
**Expertise**: Longevity research, aging biology, transcriptomic clocks
**Biography**: Co-director of the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School

### Zoe Zheng
**Title**: CEO, Biosheng (China Subsidiary)
**Participation Type**: leadership
**Role in Project**: CEO, Biosheng (China Subsidiary)
**Affiliations**: Biostate AI, Biosheng
**Participation Period**: 2025-present

### Mohammad Alkweihewi
**Title**: CEO, Biostate AI MENA (KSA Subsidiary)
**Participation Type**: leadership
**Role in Project**: CEO, Biostate AI MENA (KSA Subsidiary)
**Affiliations**: Biostate AI, Biostate AI MENA
**Participation Period**: 2025-present

### Kutapa Muthanna
**Title**: CEO, Bayosthiti AI (India Subsidiary)
**Participation Type**: leadership
**Role in Project**: CEO, Bayosthiti AI (India Subsidiary)
**Affiliations**: Biostate AI, Bayosthiti AI
**Participation Period**: 2025-present

### Jeremy Sobotta
**Title**: CFO
**Participation Type**: leadership
**Role in Project**: CFO
**Affiliations**: Biostate AI
**Participation Period**: 2025-present

### Ashwin Gopinath
**Title**: Co-founder, CTO
**Participation Type**: founder
**Role in Project**: Co-founder, CTO
**Affiliations**: Biostate AI
**Participation Period**: 2023-present
**Expertise**: Mechanical engineering, AI systems development; Mechanical engineering, AI systems development
**Biography**: Former Assistant Professor of Mechanical Engineering at MIT

### David Zhang
**Title**: Co-founder, CEO
**Participation Type**: founder
**Role in Project**: Co-founder, CEO
**Affiliations**: Biostate AI
**Participation Period**: 2023-present
**Expertise**: Bioengineering, biotechnology entrepreneurship; Bioengineering, biotechnology entrepreneurship
**Biography**: Former Associate Professor of Bioengineering at Rice University. Previously raised over $110M in venture capital and achieved $21M revenue in 2022.

## Links

### [New AI Tool Demonstrates Potential to Accelerate Longevity Research](https://longevity.technology/news/new-ai-tool-demonstrates-potential-to-accelerate-longevity-research/)
**Type**: news_article
**Relevance**: secondary
**Category**: source
**Relationship Description**: News article about K-Dense Beta and longevity research
**Publisher**: Longevity Technology
**Publication Date**: 2025-09-01
**Description**: News article about K-Dense Beta and its impact on longevity research

### [Biostate AI Unlocks Molecular Doors to Global Health with Alliances from Boston to Bengaluru](https://www.globenewswire.com/news-release/2025/07/24/3121102/0/en/Biostate-AI-unlocks-molecular-doors-to-global-health-with-alliances-from-Boston-to-Bengaluru.html)
**Type**: press_release
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Press release about global expansion
**Publisher**: GlobeNewswire
**Publication Date**: 2025-07-24
**Description**: Press release about global expansion and strategic partnerships

### [K-Dense Analyst: Towards Fully Automated Scientific Analysis](https://arxiv.org/abs/2508.07043)
**Type**: research_publication
**Relevance**: primary
**Category**: publication
**Relationship Description**: Preprint paper describing K-Dense Analyst system
**Publisher**: arXiv
**Publication Date**: 2025-08-09
**Authors**: Orion Li, Vinayak Agarwal, Summer Zhou, Ashwin Gopinath, Timothy Kassis
**Description**: Preprint paper describing K-Dense Analyst system architecture and capabilities
**Metadata**:
```yaml
type: Preprint
arxiv_id: 2508.07043
```

### [Biostate AI Launches Total RNA Sequencing and Free Data Analysis AI](https://www.businesswire.com/news/home/20240708652997/en/Biostate-AI-Launches-Total-RNA-Sequencing-and-Free-Data-Analysis-AI)
**Type**: press_release
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Press release about Total RNA Sequencing product launch
**Publisher**: Business Wire
**Publication Date**: 2025-07-08
**Description**: Press release about Total RNA Sequencing product launch

### [Biostate AI Launches K-Dense Beta, an AI Agent That Compresses Research Cycles from Years to Days; Validated with Harvard Longevity Discovery Breakthrough](https://www.globenewswire.com/news-release/2025/09/17/3151632/0/en/Biostate-AI-Launches-K-Dense-Beta-an-AI-Agent-That-Compresses-Research-Cycles-from-Years-to-Days-Validated-with-Harvard-Longevity-Discovery-Breakthrough.html)
**Type**: press_release
**Relevance**: primary
**Category**: publication
**Relationship Description**: Press release announcing K-Dense Beta launch
**Publisher**: GlobeNewswire
**Publication Date**: 2025-09-17
**Description**: Official press release announcing K-Dense Beta launch and Harvard Medical School validation

### [Biostate AI Expands Global Reach with Strategic Partnerships in US, China, and India](https://www.startuphub.ai/ai-news/sponsored-press-release/2025/biostate-ai-expands-global-reach-with-strategic-partnerships-in-us-china-and-india/)
**Type**: press_release
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Press release about global partnerships expansion
**Publisher**: StartupHub.ai
**Publication Date**: 2025-07-24
**Description**: Press release about global partnerships expansion

### [Biostate AI Raises USD 12 Mn Series A Led by Accel](https://www.entrepreneur.com/en-in/news-and-trends/biostate-ai-raises-usd-12-mn-series-a-led-by-accel/491974)
**Type**: news_article
**Relevance**: secondary
**Category**: source
**Relationship Description**: News article about Series A funding
**Publisher**: Entrepreneur
**Publication Date**: 2025-05-21
**Description**: News article about Series A funding round

### [K-Dense Beta Outperforms GPT-5 in Bioinformatics Benchmark Tests](https://sahyadristartups.com/spotlight/k-dense-beta-outperforms-gpt-5-in-bioinformatics-benchmark-tests/)
**Type**: news_article
**Relevance**: secondary
**Category**: source
**Relationship Description**: News article about BixBench performance
**Publisher**: Sahyadri Startups
**Publication Date**: 2025-09-01
**Description**: News article about K-Dense Beta's performance on BixBench benchmark

### [Biostate AI Raises $12M Series A to Transform RNA Sequencing for Precision Medicine](https://hlth.com/insights/news/biostate-ai-raises-12m-series-a-to-transform-rna-sequencing-for-precision-medicine-2025-05-21)
**Type**: news_article
**Relevance**: secondary
**Category**: source
**Relationship Description**: News article about Series A funding
**Publisher**: HLTH
**Publication Date**: 2025-05-21
**Description**: News article about Series A funding and company mission

### [Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia Care](https://www.businesswire.com/news/home/20250422686955/en/Biostate-AI-and-Weill-Cornell-Medicine-Collaborate-to-Develop-AI-Models-for-Personalized-Leukemia-Care)
**Type**: press_release
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Press release about Weill Cornell Medicine partnership
**Publisher**: Business Wire
**Publication Date**: 2025-04-22
**Description**: Press release about Weill Cornell Medicine partnership

### [Biostate AI Launches K-Dense Beta to Accelerate Biological Discovery from Years to Days](https://discover-pharma.com/biostate-ai-launches-k-dense-beta-to-accelerate-biological-discovery-from-years-to-days/)
**Type**: news_article
**Relevance**: secondary
**Category**: source
**Relationship Description**: News article about K-Dense Beta launch
**Publisher**: Discover Pharma
**Publication Date**: 2025-09-01
**Description**: News article about K-Dense Beta launch and capabilities

### [Biostate AI's Indian Subsidiary Bayosthiti Partners with Narayana Health to Build World's Largest India-Specific Cardiac AI Dataset](https://www.prnewswire.com/news-releases/biostate-ais-indian-subsidiary-bayosthiti-partners-with-narayana-health-to-build-worlds-largest-india-specific-cardiac-ai-dataset-302598587.html)
**Type**: press_release
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Press release about Narayana Health partnership
**Publisher**: PR Newswire
**Publication Date**: 2025-10-29
**Description**: Press release about Narayana Health partnership

### [Biostate AI and Accelerated Cure Project Partner to Develop AI Models for Multiple Sclerosis](https://www.prnewswire.com/news-releases/biostate-ai-and-accelerated-cure-project-partner-to-develop-ai-models-for-multiple-sclerosis-302431207.html)
**Type**: press_release
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Press release about Accelerated Cure Project partnership
**Publisher**: PR Newswire
**Publication Date**: 2025-04-17
**Description**: Press release about Accelerated Cure Project partnership

## Financials

### funding
**Amount**: $12 million USD
**Amount (Numeric)**: 12000000
**Funding Date**: 2025-05-20
**Source**: Venture Capital
**Funding Type**: Series A
**Description**: Series A funding round led by Accel
**Details**:
```yaml
investors:
  - Accel (Lead)
  - Gaingels
  - Mana Ventures
  - InfoEdge Ventures
  - Matter Venture Partners
  - Vision Plus Capital
  - Catapult Ventures
  - Dario Amodei (Anthropic)
  - Emily Leproust (Twist Bioscience)
  - Mike Schnall-Levin (10x Genomics)
lead_investor: Accel
```

### funding
**Amount**: $4 million USD
**Amount (Numeric)**: 4000000
**Funding Date**: 2024-07-09
**Source**: Venture Capital
**Funding Type**: Seed
**Description**: Seed funding round
**Details**:
```yaml
investors:
  - Matter Venture Partners
  - Vision Plus Capital
  - Catapult VC
  - Caltech Seed Fund
  - Dario Amodei (Anthropic)
  - Joris Poort
  - Michael Schnall-Levin (10x Genomics)
  - Emily Leproust (Twist Bioscience)
```

## Events

### Launched Total RNA Sequencing and Free Data Analysis AI
**Date**: 2024-07-01
**Type**: launch
**Description**: Product launch of Total RNA Sequencing technology and free data analysis AI
**Details**:
```yaml
type: Product Launch
products:
  - BIRT
  - Total RNA Sequencing
```

### Announced partnership with Accelerated Cure Project for multiple sclerosis AI models
**Date**: 2025-04-17
**Type**: partnership
**Description**: Partnership announcement with Accelerated Cure Project to develop AI models for multiple sclerosis
**Details**:
```yaml
type: Partnership
focus: Multiple sclerosis AI models
partner: Accelerated Cure Project
```

### Announced collaboration with Weill Cornell Medicine for personalized leukemia care AI models
**Date**: 2025-04-22
**Type**: partnership
**Description**: Partnership announcement with Weill Cornell Medicine to develop AI models for personalized leukemia care
**Details**:
```yaml
type: Partnership
focus: Personalized leukemia care AI models
partner: Weill Cornell Medicine
```

### Raised $12 million Series A round led by Accel
**Date**: 2025-05-20
**Type**: funding
**Description**: Series A funding round announcement
**Details**:
```yaml
type: Funding
amount: $12 million
lead_investor: Accel
```

### Announced partnerships with Mass General Brigham (melanoma immunotherapy) and Kindstar Global Gene Technology (China joint venture)
**Date**: 2025-07-24
**Type**: partnership
**Description**: Multiple partnership announcements including Mass General Brigham and Kindstar Global Gene Technology
**Details**:
```yaml
type: Partnership
partners:
  - Mass General Brigham
  - Kindstar Global Gene Technology
```

### Launched K-Dense Beta, a multi-agent AI research system validated with Harvard Medical School longevity research breakthrough
**Date**: 2025-09-17
**Type**: launch
**Description**: Product launch of K-Dense Beta with validation results from Harvard Medical School
**Details**:
```yaml
type: Product Launch
product: K-Dense Beta
validation: Harvard Medical School longevity research breakthrough
```

### Bayosthiti AI (India subsidiary) partnered with Narayana Health to build world's largest India-specific cardiac AI dataset
**Date**: 2025-10-29
**Type**: partnership
**Description**: Partnership announcement through Indian subsidiary with Narayana Health
**Details**:
```yaml
type: Partnership
focus: India-specific cardiac AI dataset
partner: Narayana Health
subsidiary: Bayosthiti AI
```

## Partnerships

### technology
**Date**: 2025-01-01
**Focus**: Drug discovery acceleration
**Description**: K-Dense accelerated a three-month research project to four days, discovering previously unrecognized patterns of cell states associated with compound response
**Partner Organizations**:
- Biostate AI (partner)
  - K-Dense Beta provider for drug discovery validation study
- Zafrens (partner)
  - Validation study partner for drug discovery acceleration
**Details**:
```yaml
discovery: Previously unrecognized patterns of cell states associated with compound response
collaborator: Swamy Vijayan, CEO Zafrens
validation_result: K-Dense accelerated a three-month research project to four days
```

### research
**Date**: 2025-10-29
**Focus**: Cardiovascular disease prediction for Indian populations
**Description**: Partnership through Indian subsidiary Bayosthiti AI to develop AI models specifically designed to predict cardiovascular disease in Indian populations. Building world's largest India-specific cardiac AI dataset
**Partner Organizations**:
- Biostate AI (partner)
  - AI platform provider through Indian subsidiary Bayosthiti AI
- Narayana Health (partner)
  - Research collaborator for cardiovascular disease prediction in Indian populations
**Details**:
```yaml
subsidiary: Bayosthiti AI
dataset_scale: "World's largest India-specific cardiac AI dataset"
```

### research
**Date**: 2025-04-17
**Focus**: Multiple sclerosis AI models, disease progression prediction
**Description**: Partnership to develop next-generation AI models capable of predicting disease progression and treatment response in multiple sclerosis
**Partner Organizations**:
- Biostate AI (partner)
  - AI platform provider for multiple sclerosis research
- Accelerated Cure Project (partner)
  - Research collaborator for multiple sclerosis AI models

### research
**Date**: 2025-04-01
**Focus**: Personalized leukemia care, disease prognosis AI
**Description**: Collaboration to develop AI models for personalized assessments of patient disease prognosis and evolution, initially focusing on leukemia
**Partner Organizations**:
- Biostate AI (partner)
  - AI platform provider for personalized leukemia care research
- Weill Cornell Medicine (partner)
  - Research collaborator for personalized leukemia care AI models

### commercial
**Date**: 2025-07-24
**Focus**: China market adaptation, RNA sequencing platform
**Deal Structure**: Joint Venture
**Description**: Formed joint venture in China to adapt Biostate AI's RNA sequencing and AI platform for the Chinese population, focusing on five high-prevalence medical areas
**Partner Organizations**:
- Biostate AI (partner)
  - Joint venture partner providing RNA sequencing and AI platform
- Kindstar Global Gene Technology (partner)
  - Joint venture partner for China market adaptation

### research
**Date**: 2025-07-24
**Focus**: Melanoma immunotherapy AI models
**Description**: Collaboration to develop AI models for melanoma immunotherapy, specifically targeting immune checkpoint inhibitor treatments to improve safety and efficacy
**Partner Organizations**:
- Biostate AI (partner)
  - AI platform provider for melanoma immunotherapy research
- Mass General Brigham (partner)
  - Research collaborator for melanoma immunotherapy AI models

### research
**Date**: 2025-01-01
**Focus**: Transcriptomic aging clock development, longevity research
**Description**: Validated K-Dense Beta's capabilities in longevity research study analyzing over 600,000 transcriptomic profiles. K-Dense selected 60,000 high-quality samples and focused on 5,000 genes out of more than 50,000 available. The system identified 4 new RNA proteins related to aging. Professor David Sinclair, co-director of the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School, noted that K-Dense enabled completion of the research in weeks, whereas traditional methods would have taken months or years. The system pointed to markers and pathways requiring deeper investigation and helped create a unified AI model for predicting biological age. Achieved industry-leading accuracy while compressing research cycles from years to days. Results submitted to bioRxiv and awaiting peer-reviewed journal publication.
**Partner Organizations**:
- David Sinclair Lab - Harvard Medical School (partner)
  - Research collaborator and validation partner for longevity research study
- Biostate AI (partner)
  - Primary developer and provider of K-Dense Beta system
**Details**:
```yaml
validation_details:
  discoveries: 4 new RNA proteins related to aging
  key_insight: Aging is a sequence of biological programs requiring individual predictive models
  genes_focused: 5,000 genes from 50,000+ available
  samples_selected: 60,000 high-quality samples
  time_compression: Weeks instead of months or years
  profiles_analyzed: 600,000+ transcriptomic profiles
  publication_status: Preprint on bioRxiv, awaiting peer review
```
